Rasio Therapeutics
Baltimore, US · Founded 2019 · Delaware corporation
Founders & leadership
RK
Raju KucherlapatiNamed on SEC filing
SB
Sujuan BaNamed on SEC filing
KM
Ken MaloneNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2021
▶$1.5MraisedNov 2021 · 2 investors · BiotechnologyRule 506(b)
▶$1.5MraisedNov 2021 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Raju KucherlapatiDirector
- Sujuan BaDirector
- Ken MaloneExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Rasio Therapeutics raised?
- Rasio Therapeutics has disclosed $1.5M raised across 1 round.
- Where is Rasio Therapeutics headquartered?
- Rasio Therapeutics is headquartered in Baltimore, US.